Adult: Coronary
Sequential multidetector computed tomography assessments after venous graft treatment solution in coronary artery bypass grafting

Read at the 99th Annual Meeting of The American Association for Thoracic Surgery, Toronto, Ontario, Canada, May 4-7, 2019.
https://doi.org/10.1016/j.jtcvs.2019.10.115Get rights and content
Under an Elsevier user license
open archive

Abstract

Objectives

To assess the effect of DuraGraft (Somahlution Inc, Jupiter, Fla), an intraoperative graft treatment, on saphenous vein grafts in patients undergoing isolated coronary artery bypass grafting.

Methods

Within patients, 2 saphenous vein grafts were randomized to DuraGraft or heparinized saline. Multidetector computed tomography angiography at 1, 3, and 12 months assessed change in wall thickness (primary end point at 3 months), lumen diameter, and maximum narrowing for the whole graft and the proximal 5-cm segment. Safety end points included graft occlusion, death, myocardial infarction, and repeat revascularization.

Results

At 3 months, no significant changes were observed between DuraGraft- and saline-treated grafts (125 each) for wall thickness, lumen diameter, and maximum narrowing. At 12 months, DuraGraft-treated grafts demonstrated smaller mean wall thickness, overall (0.12 ± 0.06 vs 0.20 ± 0.31 mm; P = .02) and in the proximal segment (0.11 ± 0.03 vs 0.21 ± 0.33 mm; P = .01). Changes in wall thickness were greater in the proximal segment of saline-treated grafts (0.09 ± 0.29 vs 0.00 ± 0.03 mm; P = .04). Increase in maximum graft narrowing was larger in the proximal segment in the saline-treated grafts (4.7% ± 12.7% vs 0.2% ± 3.8%; P = .01). Nine DuraGraft and 11 saline grafts had occluded or thrombosed. One myocardial infarction was associated with a saline graft occlusion. No deaths or revascularizations were observed.

Conclusions

DuraGraft demonstrated a favorable effect on wall thickness at 12 months, particularly in the proximal segment. Longer-term follow-up in larger studies is needed to evaluate the effect on clinical outcomes.

Graphical abstract

DuraGraft (Somahlution Inc, Jupiter, Fla) resulted in smaller wall thickness at 12 months versus saline.

  1. Download : Download high-res image (123KB)
  2. Download : Download full-size image

Key Words

saphenous vein graft
vein graft disease
computed tomography
coronary artery bypass grafting
patency
endothelial damage inhibitor

Abbreviations and Acronyms

CABG
coronary artery bypass grafting
MDCT
multidetector computed tomography
SVG
saphenous vein graft
TVD
total vessel diameter
VGD
vein graft disease
VGF
vein graft failure

Cited by (0)